BeStock  
Stocks › Medical Devices › PACB

Pacific Biosciences of California PACB

US equityMarket cap rank #3575Medical Devices
$1.63 −$0.13 (-7.39%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $1.63 +0.28%
Open$1.69
Prev close$1.76
Day range$1.61 – $1.73
Volume13.69M
Market cap$510.07M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

PACB at a glance

PACB last changed hands at $1.63 (down 7.39%). At $510.07M, Pacific Biosciences of California is ranked #3575 by size among the 3753 stocks on BeStock.

The stock's 52-week band runs $1.07 to $3.44, and the latest print sits 52.5% under the top end of it. Holders are behind 26.6% over twelve months, but up 27.3% across the last three months.

Price is below the 50-day average ($2.05) but above the 200-day ($1.60); RSI is 35, and the last 30 sessions moved at roughly 107% annualized volatility.

In the quarter ended Sep 2026 the company brought in $40.56M of revenue, up 5.5% from a year earlier, and a net loss of $37.85M.

5 analysts follow the stock and the average call is "hold". The mean target, $2.64, sits 62.0% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$1.61 / $1.66
Average price today$1.66
Volume13.69MAvg (90d) 11.52M
Turnover$22.75M
Turnover rate4.47%of shares outstanding
Volume ratio0.98vs. recent average pace
Day amplitude6.82%
Market cap$510.07M
Float market cap$499.22M
Shares outstanding306.27M
EPS (TTM)-$1.82
P/B-8.32
Book value / share-$0.20
Net profit (TTM)-$569.53M
Net assets-$61.33M
30-day volatility107.0%annualized
Avg daily range (ATR)14.72%of price, 14 days
Max drawdown (1y)-58.4%-43.8% from 1y peak

Quote as of Nov 21, 2026 9:10 am ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

D
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

C
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

C
Wall Street

5 analysts, consensus Hold.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 6.3 · 2026-11-22 08:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability5.2
Momentum58.9
Financial health10.0
Analyst view46.7

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$2.64+62.0% vs. current price
Consensus ratingHold5 analysts covering
Morningstar fair value$3.55Price is below fair value

Wall Street’s average 12-month target is $2.64, 62.0% above today’s price, with a consensus rating of Hold. Morningstar’s fair value model puts the stock at $3.55, so shares trade 54.1% below that estimate. On earnings multiple, it sits in the 47th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-7.4%
1 week
-16.8%
1 month
-20.9%
3 months
+27.3%
6 months
+33.6%
Year to date
-12.8%
1 year
-26.6%
Day range
$1.61$1.73
52-week range
$1.07$3.44

Technical signals

Full technicals →
Trend readLeaning bearish

2 bullish · 5 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-26.9%Bearish
Price vs 50-day average-20.6%Bearish
Price vs 200-day average+2.2%Bullish
50-day vs 200-day50d above 200dBullish
RSI (14)35.2Bearish
MACD (12,26,9)-0.11Bearish
Bollinger band position8%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How PACB ranks on BeStock

Market value#3557 of 3734
Closeness to 52-week high#3107 of 3724
Dollar volume today#1929 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

PACB is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on PACB.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on PACB

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

PACB stock: common questions

How is Pacific Biosciences of California stock doing today?

$1.63 is the latest print for PACB, a move of -7.39% against yesterday's close of $1.76. Today's low and high so far: $1.61 and $1.73.

What is PACB worth in total?

Equity value comes to $510.07M at the current price. By that measure it is number 3575 of the 3753 names in our coverage.

Where does PACB sit in its 52-week range?

The year's floor is $1.07 and the ceiling $3.44. Shares are 52.5% away from that ceiling.

Does PACB send cash back through a dividend?

Our data shows no dividend paid by Pacific Biosciences of California over the trailing twelve months.

Do Wall Street analysts like PACB?

Of 5 analysts, 40% say buy, 40% hold and 20% sell. Price targets average $2.64, with the most cautious at $2.00 and the most optimistic at $3.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on PACB.

Sign in to join the discussion.

Scroll to Top